Journal papers and conference posters

• 2006 
• 2005 
• 2004 
• 2003 
• 2002 
• 2001 

HPA CDR-Weekly publications are listed under the Epidemiological data section of the website.

Guidelines can be found under the Guidance section  of the website.

2006

• Reynaud Af Geijersstam AH, et al. Antimicrobial susceptibility and molecular analysis of Enterococcus faecalis originating from endodontic infections in Finland and Lithuania. Oral Microbiol Immunol. 2006 Jun; 21(3):164-8.

2005

• Mushtaq S, et al. Activity Of Cephalosporin PPI-0903M vs. Critical Resistance Types [poster]. (PDF, 103 KB)
  
   45th ICAAC conference; 2005 Dec; Washington, US.
• Warner M, et al. Activity of Oxazolidinone Rwj-416457 vs. Linezolid-Resistant and -Susceptible Staphylococci and Enterococci [poster]. (PDF, 121 KB)
  
  (121kB) 45th ICAAC conference; 2005 Dec; Washington, US.
• Wagner K, et al. Mandatory and voluntary surveillance of glycopeptide-resistant enterococcal bacteraemia [poster]. (PDF, 599 KB)
  
  HPA Conference; 2005 Sep; Warwick, UK.
• Woodford N. Biological counterstrike: antibiotic resistance mechanisms of gram-positive cocci. Clin. Microbiol. Infect. 2005 May; 11 Suppl 3:2-21.

2004

• Johnson AP, et al. Activity of daptomycin against multi-resistant gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid. Int. J. Antimicrob. Agents. 2004 Oct; 24(4):315-9.
• Johnson AP, et al. Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar. J. Antimicrob. Chemother. 2004 May; 53(5):860-2.
• King L, on behalf of the National Glycopeptide Resistant Enterococcal Bacteraemia Surveillance Working Group in England. Surveillance of glycopeptide-resistant enterococcal bacteraemias in England [poster]. (PDF, 90 KB)
  
    14th ECCMID conference; 2004 May; Prague, Czech Republic.
• Stockdale MW, et al. Low in-vitro selection frequencies of enterococcal and staphylococcal mutants resistant to the oxazolidinone AZD2563. Internat. J. Antimicrob. Agents. 2004 Jan; 23(1):88-91.   

2003

• Sinclair A, et al. Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in enterococci. Antimicrob. Agents Chemother. 2003 Nov;47(11):3620-2.
• Solway S, et al. Isolation of streptogramin-resistant Enterococcus faecium from human and non-human sources in a rural community. J. Antimicrob. Chemother. 2003 Oct;52(4):707-10.
• Willems RJ, et al. Occurrence of mutations in the DNA mismatch repair proteins MutS and MutL of oxazolidinone -resistant and -susceptible Enterococcus faecium strains. Antimicrob. Agents Chemother. 2003 Oct; 47(10):3061-6.
• Woodford N, et al. Two widely-disseminated strains of Enterococcus faecalis highly-resistant to gentamicin and ciprofloxacin from bacteraemias in the United Kingdom and Ireland. J. Antimicrob. Chemother. 2003 Oct; 52(4):711-4.
• Johnson AP, et al. Calcium-Supplemented E-test Strips for Susceptibility Testing With Daptomycin [poster]. (PDF, 48 KB)
  
  43rd ICAAC conference; 2003 Sep; Chicago, US.
• Johnson AP, et al. Activity of Daptomycin Against Multi-resistant Gram-positive Bacteria Including Enterococci and Resistant to Linezolid [poster]. (PDF, 47 KB)
  
  43rd ICAAC conference; 2003 Sep; Chicago, US.
• Sinclair A, et al. Rapid Estimation by Pyrosequencing of 23S rRNA Alleles Containing a T2576 Mutation in Linezolid-Resistant and -Susceptible Enterococci [poster]. (PDF, 600 KB)
  
  43rd ICAAC conference; 2003 Sep; Chicago, US.
• Johnson AP, et al.; ICU Study Group. Susceptibility of Gram-positive bacteria from ICU patients in UK hospitals to antimicrobial agents J. Hosp. Infect. 2003 Jul; 54(3):179-87.
• Willems RJ, et al. Occurrence of mutations in the DNA mismatch repair proteins MutS and MutL of oxazolidinone-resistant and -susceptible strains [poster]. (PDF, 377 KB)
  
  23rd ICC conference; 2003 Jun; Durban, South Africa.
• Woodford N, et al. Identification of two widely disseminated strains of highly-resistant to gentamicin and ciprofloxacin causing bacteraemias in the United Kingdom [poster]. (PDF, 1.7 MB)
  
  13th ECCMID conference; 2003 May; Glasgow, UK.

2002

• Auckland C, et al. Linezolid-resistant enterococci: report of the first isolates in the United Kingdom. J. Antimicrob. Chemother. 2002 Nov;50(5):743-6.
• Woodford N, et al. Detection of oxazoliinone-resistant Enterococcus faecalis and Enterocuccus faecium strains by real-time PCR and PCR-RFLP analysis. J. Clin. Microbiol. 2002 Nov; 40(11):4298-300.
• Johnson AP, et al. Emerging linezolid resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit. Eur J Clin Microbiol Infect Dis. 2002 Oct;21(10):751-4.
• British Society for Antimicrobial Chemotherapy Extended Working Party on Bacteraemia Resistance Surveillance and Central Public Health Laboratory. Resistance among pathogens of bacteraemia in the UK assessed by sentinel surveillance and routine data. (PDF, 178 KB)
  
  42nd ICAAC conference; 2002 Sep; San Diego, US.
• Woodford N, et al. Enterococcal and staphylococcal resistance to the new oxazolidinone AZD2563 is difficult to select in vitro [poster]. (PDF, 52 KB)
  
  42nd ICAAC conference; 2002 Sep; San Diego, US.
• Woodford N, et al. Detection of linezolid-resistant enterococci by real-time PCR and PCR-RFLP analysis [poster]. (PDF, 721 KB)
  
    42nd ICAAC conference; 2002 Sep; San Diego, US.
• Johnson AP, et al. In-vitro activity of a novel oxazolidinone, AZD2563, against randomly-selected and multi-resistant Gram-positive cocci. J. Antimicrob. Chemother. 2002 Jul; 50(1):89-93.

2001

• Demertzi E, et al. Characterization of VanA and VanB elements from glycopeptide-resistant Enterococcus faecium from Greece. J. Med. Microbiol. 2001 Aug; 50(8):682-7.
• McGregor KF, et al. Prevalence of the vanB2 gene cluster in VanB glycopeptide-resistant enterococci in the United Kingdom and the Republic of Ireland and its association with a Tn5382-like element. Antimicrob. Agents Chemother. 2001 Jan; 45(1):367-8.
• Moore JE, et al. A rapid molecular assay for the detection of antibiotic resistance determinants in causal agents of infective endocarditis. J. Appl. Microbiol. 2001 May; 90(5):719-26.
• Soltani M, et al. Identification of vat(E-3), a novel gene encoding resistance to quinupristin-dalfopristin in a strain of Enterococcus faecium from a hospital patient in the United Kingdom. Antimicrob. Agents Chemother. 2001 Feb; 45(2):645-6.
• Tremlett CH, et al. Identification of two structurally distinct VanA elements at different locations in a glycopeptide-resistant strain of Enterococcus faecalis. Antimicrob. Agents Chemother. 2001 Mar; 45(3):996-997.
• Woodford N. Glycopeptide resistance in enterococci and Staphylococcus aureus: current and future concerns. Eur. J. Pharmaceut. Sci. 2001; 13 (suppl. 1): S9.
• Woodford N. Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci. Microb. Drug Resist. 2001 Fall; 7(3):229-36.
• Woodford N, et al. Frequency of esp in Enterococcus faecium isolates. Lancet. 2001 Aug 18; 358(9281):584.

 

• Enterococcus species past publications
  Added/updated: 21 October 2011